Aspartate

Aspartate (the conjugate base of aspartic acid, abbreviated Asp or D; IUPAC name (2*S*)-2-aminobutanedioic acid; molecular formula C₄H₇NO₄; molecular mass 133.10 Da) is one of the twenty standard proteinogenic α-amino acids encoded by the genetic code codons GAU and GAC. First discovered in 1827 by Auguste-Arthur Plisson and Étienne Ossian Henry via alkaline hydrolysis of asparagine extracted from asparagus juice, aspartic acid carries a short β-carboxylic acid side chain (–CH₂–COOH) with an aqueous dissociation constant of pK_aR = 3.65 to 3.90 (alongside α-COOH pK_a1 = 1.88 and α-NH₃⁺ pK_a2 = 9.60, giving an acidic isoelectric point of pI = 2.77). At physiological pH 7.4, more than 99.9% of free and solvent-exposed side chains exist in the deprotonated, negatively charged β-carboxylate state (–CH₂–COO⁻), which is therefore referred to throughout biochemistry as aspartate.

Nutritionally non-essential in humans, aspartate sits at the crossroads of intermediary carbon, nitrogen, and energy metabolism. Directly interconvertible in a single step with the citric acid cycle (TCA) intermediate oxaloacetate via pyridoxal-5′-phosphate (PLP)-dependent transamination, aspartate operates as (1) the essential electron-carrying metabolite of the malate-aspartate shuttle across the inner mitochondrial membrane; (2) the obligatory second nitrogen donor in the hepatic urea cycle; (3) the direct precursor of both pyrimidine and purine rings required for DNA and RNA replication; and (4) a catalytic carboxylate ligand that chelates divalent Mg²⁺ ions in the active sites of all replicative DNA and RNA polymerases.

Pyridoxal-5′-Phosphate (PLP) Transamination by Aspartate Aminotransferase (AST)

Both the biosynthesis and catabolism of aspartate proceed through a reversible ping-pong bi-bi transamination reaction catalyzed by aspartate aminotransferase (AST, also termed glutamate-oxaloacetate transaminase, GOT; EC 2.6.1.1), which requires the vitamin B₆ coenzyme pyridoxal-5′-phosphate (PLP) covalently bound as an internal aldimine (Schiff base) to an active-site lysine residue:

L-Glutamate + Oxaloacetate ⇌ α-Ketoglutarate + L-Aspartate (ΔG°′ ≈ 0 kJ/mol)

In the first half-reaction, L-glutamate displaces the active-site lysine to form an external aldimine with PLP; abstraction of the Cα proton generates a resonance-stabilized carbanion (quinonoid intermediate) that reprotonates at the C4′ carbon of the cofactor to form a ketimine, which hydrolyzes to release α-ketoglutarate and leave the cofactor in its aminated pyridoxamine-5′-phosphate (PMP) state. In the second half-reaction, the four-carbon α-ketoacid oxaloacetate binds to PMP and reverses the mechanistic steps to regenerate PLP-enzyme and release L-aspartate. Mammalian cells express two compartmentalized isoenzymes—cytosolic AST1 (cAST) and mitochondrial matrix AST2 (mAST)—and elevated serum AST activity (evaluated alongside alanine aminotransferase, ALT) serves as a cornerstone clinical diagnostic biomarker of hepatocellular necrosis or myocardial infarction.

The Malate-Aspartate Shuttle and Mitochondrial NADH Transport

Because the inner mitochondrial membrane is impermeable to cytosolic NADH generated during glycolysis, high-energy aerobic tissues (heart, liver, and kidney) rely on the malate-aspartate shuttle—driven by the tandem action of cytosolic and mitochondrial malate dehydrogenase (MDH) and aspartate aminotransferase (AST)—to transfer reducing equivalents into the mitochondrial matrix without losing ATP yield:

1. Cytosolic Reduction of Oxaloacetate: Cytosolic malate dehydrogenase (MDH1) uses glycolytic NADH + H⁺ to reduce oxaloacetate to L-malate (regenerating cytosolic NAD⁺ to sustain glyceraldehyde-3-phosphate dehydrogenase).
2. Electroneutral Malate/α-Ketoglutarate Antiporter (SLC25A11): L-Malate enters the mitochondrial matrix in exchange for matrix α-ketoglutarate.
3. Matrix Re-Oxidation and Transamination to Aspartate: Mitochondrial MDH2 oxidizes L-malate back to oxaloacetate, directly reducing matrix NAD⁺ to NADH + H⁺ for Complex I of the electron transport chain (~2.5 ATP per NADH). Because oxaloacetate cannot cross the inner mitochondrial membrane directly, mitochondrial AST2 transaminates oxaloacetate with matrix glutamate to form L-aspartate and α-ketoglutarate.
4. Electrogenic Aspartate/Glutamate Antiporter (AGC1/Aralar & AGC2/Citrin, SLC25A12/13): Aspartate⁻ is exported to the cytosol in exchange for cytosolic glutamate⁻ + H⁺ (driven thermodynamically by the proton-motive membrane potential Δψ across the inner membrane), where cytosolic AST1 converts aspartate back into oxaloacetate to complete the cycle.

Nitrogen Donation to the Urea Cycle and De Novo Nucleotide Synthesis

Unlike most amino acids that release ammonia via oxidative deamination, aspartate donates its α-amino nitrogen directly via ATP-driven condensation reactions—using fumarate as a recyclable carbon skeleton—across three major biosynthetic pathways:

• Hepatic Urea Cycle: One nitrogen atom of urea ((NH₂)₂C=O) derives from free mitochondrial NH₄⁺ (via carbamoyl phosphate), while the second nitrogen atom is supplied specifically by cytosolic L-aspartate. Argininosuccinate synthetase (ASS1) condenses citrulline with aspartate (via a citrullyl-AMP intermediate) to form argininosuccinate, which argininosuccinate lyase (ASL) cleaves into L-arginine and fumarate. Fumarate is hydrated by fumarase to malate and oxidized back to oxaloacetate, forming the Krebs bicycle linking the TCA cycle and the urea cycle.
• De Novo Pyrimidine Biosynthesis: In the second step of pyrimidine synthesis, aspartate transcarbamoylase (ATCase) condenses carbamoyl phosphate with the entire molecule of L-aspartate to form N-carbamoylaspartate, which cyclizes via dihydroorotase to orotate; thus, atoms N1, C4, C5, and C6 of every cytosine, uracil, and thymine base in DNA and RNA originate directly from aspartate.
• De Novo Purine Biosynthesis (IMP and the Purine Nucleotide Cycle): Aspartate donates the N1 ring nitrogen of the purine bicycle (via SAICAR synthetase) and subsequently donates the exocyclic 6-amino group of adenine when adenylosuccinate synthetase condenses inosine monophosphate (IMP) with aspartate (driven by GTP hydrolysis) to form adenylosuccinate, which adenylosuccinate lyase cleaves to AMP + fumarate. In plants and bacteria, aspartate is also the starting precursor of the aspartate-family pathway (via aspartokinase) that synthesizes four essential dietary amino acids: lysine, methionine, threonine, and isoleucine.

The Universal Two-Metal-Ion (Mg²⁺) Mechanism in DNA and RNA Polymerases

Because the deprotonated β-carboxylate of aspartate carries two negatively charged, sp²-hybridized oxygen atoms with high charge density (a Pearson "hard" Lewis base), conserved aspartate dyads and triads serve as the universal coordination scaffold for hard divalent Mg²⁺ (or Mn²⁺) cations across nucleic-acid enzymes. As elucidated by Lorena Beese and Thomas Steitz (1991, 1998), virtually all replicative DNA polymerases, RNA polymerases, reverse transcriptases, transposases, self-splicing Group I/II introns, and RuvC nuclease domains (including CRISPR-Cas9) share a catalytic palm core containing two or three invariant aspartate residues (such as the signature G–D–D or Y–M–D–D motif) that coordinate two catalytic Mg²⁺ ions (Metal A and Metal B) separated by ~3.8–4.0 Å:

• Metal A (Nucleophile Activation): Coordinated by two active-site aspartates and the 3′-OH terminus of the growing primer strand, Metal A acts as a Lewis acid to lower the pK_a of the primer 3′-OH from ~14 to ~7, facilitating its deprotonation to a potent 3′-O⁻ alkoxide nucleophile that executes an inline S_N2 attack on the α-phosphorus (Pα) of the incoming deoxynucleoside triphosphate (dNTP).
• Metal B (Triphosphate Alignment and Leaving-Group Stabilization): Coordinated by the same bridging aspartate carboxylate plus the non-bridging oxygens of the α-, β-, and γ-phosphates of the incoming dNTP, Metal B neutralizes the negative charge of the pentacovalent trigonal-bipyramidal phosphorane transition state and stabilizes the departing pyrophosphate (PP_i²⁻) leaving group.

Aspartic Proteases, Serine Protease Triads, and P-Type ATPase Phosphorylation

Beyond metal chelation, buried or hydrogen-bonded aspartate residues drive three major classes of non-metallic enzymatic catalysis:

1. Aspartic Proteases (HIV-1 Protease, Pepsin, Renin, and Cathepsin D): Contain a symmetric or pseudosymmetric pair of active-site aspartates (such as the Asp25 / Asp25′ dyad in the homodimeric HIV-1 protease, each within a conserved Asp–Thr–Gly triad) positioned within hydrogen-bonding distance (~2.8 Å) at the base of the substrate-binding cleft. Because of electrostatic repulsion between the two closely apposed carboxylates, one aspartate remains deprotonated (pK_a1 ≈ 3.0–3.5, acting as a general base to activate a bound catalytic H₂O molecule for nucleophilic attack on the scissile amide carbonyl), while the second aspartate remains protonated (pK_a2 ≈ 5.0–6.0, acting as a general acid to protonate the carbonyl oxygen into a neutral gem-diol tetrahedral intermediate and subsequently protonate the departing amine nitrogen).
2. Electrostatic Orientation in the Ser–His–Asp Catalytic Triad: In serine and cysteine proteases, buried Asp102 does not touch the substrate directly; instead, its negatively charged β-carboxylate accepts a short, strong hydrogen bond from the N^δ1–H group of histidine 57, locking the imidazole ring in the correct tautomeric orientation and stabilizing the positive charge developed on the imidazolium cation during transition-state formation.
3. Covalent β-Aspartyl Phosphate Intermediates: In P-type ATPase ion pumps (including the plasma-membrane Na⁺/K⁺-ATPase, sarcoplasmic reticulum SERCA Ca²⁺-ATPase, and gastric H⁺/K⁺-ATPase) as well as bacterial two-component response regulators (such as CheY and OmpR), a single invariant aspartate attacks the γ-phosphate of ATP (or a histidine-kinase phosphohistidine) to form a high-energy mixed-anhydride β-aspartyl phosphate (acyl-phosphate) intermediate. Formation and subsequent hydrolysis of this covalent aspartyl-phosphate drives the E₁ ⇌ E₂ conformational cycle that pumps ions against steep electrochemical gradients.

Why is aspartate synthesis the primary metabolic bottleneck when cells suffer electron transport chain inhibition?

Proliferating mammalian cells require large amounts of cytosolic L-aspartate to synthesize purine and pyrimidine nucleotides and proteins. As demonstrated by Birsoy et al. (2015) and Sullivan et al. (2015), the primary physiological role of mitochondrial electron transport chain (ETC) respiration in proliferating cells—beyond ATP synthesis—is to oxidize NADH back to NAD⁺ so that malate dehydrogenase can oxidize malate to oxaloacetate, which AST transaminates to aspartate. When the ETC is inhibited, the NADH/NAD⁺ ratio rises, oxaloacetate and aspartate pools collapse, and cell division halts unless exogenous aspartate or an electron acceptor (such as pyruvate) is supplied.

How can two identical aspartate residues in HIV-1 protease have different pK_a values (~3.2 and ~5.5)?

In homodimeric HIV-1 protease, the β-carboxyl groups of Asp25 (monomer A) and Asp25′ (monomer B) sit coplanar within ~2.8 Å of each other at the bottom of a hydrophobic cleft. Once the first carboxyl group loses a proton (pK_a1 ≈ 3.1–3.5), placing a second negative charge immediately adjacent to the first incurs a strong Coulombic electrostatic repulsion penalty and allows the two oxygens to share the remaining proton in a low-barrier hydrogen bond, shifting the second ionization constant upward to pK_a2 ≈ 5.2–6.0.

Why does mutation of the conserved D–D–D/E aspartate triad completely abolish DNA polymerase or Cas9 activity?

In DNA/RNA polymerases and RuvC-family nucleases (including CRISPR-Cas9's RuvC domain), the invariant aspartate carboxylates directly coordinate the two catalytic Mg²⁺ ions required to deprotonate the attacking nucleophile (primer 3′-OH or H₂O) and stabilize the pentacovalent phosphorus transition state. Mutating these aspartates to neutral alanines (such as the D10A mutation used to create "nickase" or catalytically dead dCas9) eliminates Mg²⁺ binding, reducing phosphodiester cleavage or polymerization rates by > 10⁵-fold without disrupting DNA target binding.

1. Plisson, A.-A., & Henry, O. (1830). "Mémoire sur l'acide aspartique et sur l'asparagine." Annales de Chimie et de Physique, 45, 304–321. https://doi.org/10.1007/978-3-642-51134-9_2
2. Steitz, T. A. (1998). "A mechanism for all polymerases." Nature, 391(6664), 231–232. https://doi.org/10.1038/34542
3. Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015). "An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis." Cell, 162(3), 540–551. https://doi.org/10.1016/j.cell.2015.07.016
4. Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E., & Vander Heiden, M. G. (2015). "Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells." Cell, 162(3), 552–563. https://doi.org/10.1016/j.cell.2015.07.017